ImmuCell (ICCC) Competitor Comparison
We are evaluating the key criteria listed to compare ImmuCell (ICCC) against its competitors in the Biotechnology industry.
Market Capitalization
305 / 368Gross Profits
2 / 278Total Revenue
168 / 300EBITDA
37 / 337Free Cashflow
75 / 352Quick Ratio
321 / 357Earnings per Share
82 / 359Dividend yield
0 / 6Total Cash
346 / 358Performance 3 years
185 / 368Performance 5 years
160 / 368Performance 10 years
123 / 368Linearity 3 years
103 / 368Linearity 5 years
35 / 368Linearity 10 years
27 / 368Total Rank
152 / 368Dividend Rank
156 / 368Valuation Rank
208 / 368Piotroski Rank
342 / 368Muliplier Rank
73 / 368Piotroski Rank - ICCC ranking 342 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.